Show simple item record

The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience

dc.contributor.authorChesshyre, ELD
dc.contributor.authorBradbury, JD
dc.contributor.authorCook, H
dc.contributor.authorRocchi, F
dc.contributor.authorRoes, K
dc.contributor.authorTurner, MA
dc.contributor.authorBrüggemann, R
dc.contributor.authorWarris, A
dc.date.accessioned2025-01-15T14:04:08Z
dc.date.issued2024-10-02
dc.date.updated2025-01-15T11:57:19Z
dc.description.sponsorshipEuropean Union Horizon 2020en_GB
dc.description.sponsorshipEuropean Federation of Pharmaceutical Industries and Associations (EFPIA)en_GB
dc.identifier.citationVol. 25, No. 1, article 645en_GB
dc.identifier.doihttps://doi.org/10.1186/s13063-024-08510-1
dc.identifier.urihttp://hdl.handle.net/10871/139641
dc.identifierORCID: 0000-0003-0223-417X (Cook, Heather)
dc.identifierORCID: 0000-0001-6586-3358 (Warris, Adilia)
dc.language.isoenen_GB
dc.publisherBMCen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/39358818en_GB
dc.rights© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en_GB
dc.titleThe impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experienceen_GB
dc.typeArticleen_GB
dc.date.available2025-01-15T14:04:08Z
dc.identifier.issn1468-6708
exeter.article-number645
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available on open access from BMC via the DOI in this record. en_GB
dc.identifier.eissn1745-6215
dc.identifier.journalTrialsen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2024-09-25
dcterms.dateSubmitted2023-11-23
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2024-10-02
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2025-01-15T14:01:37Z
refterms.versionFCDVoR
refterms.dateFOA2025-01-15T14:04:46Z
refterms.panelAen_GB
refterms.dateFirstOnline2024-10-02


Files in this item

Name:
The impact of the COVID-19 ...
Size:
652.8Kb
Format:
PDF
Description:
Impact of the COVID-19 pandemic ...
View/Open

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.